Home › Heart Attack › California › Los Angeles
Heart Attack clinical trials in Los Angeles, CA
3 studies for Heart Attack are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Academic Medical Research Institute, Los Angeles
- National Institute of Clinical Research, Inc., Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- InvivoCure, Los Angeles
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RecruitingPhase 2
- Abcentra Investigational Site, Los Angeles
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- Rochester, MN6 studies
- New York City, NY6 studies
- Dallas, TX5 studies
- Boston, MA5 studies
- Knoxville, TN3 studies
- Houston, TX3 studies
- Hartford, CT3 studies
- Greensboro, NC3 studies
- Durham, NC3 studies
- Nashville, TN3 studies
- Detroit, MI3 studies
- Minneapolis, MN3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer92 studies
- Breast Cancer73 studies
- Cancer (all types)73 studies
- Prostate Cancer64 studies
- Colorectal Cancer61 studies
- Metastatic Cancer57 studies
- Ovarian Cancer53 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma43 studies
- Pancreatic Cancer36 studies
- Endometrial Cancer35 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.